Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-205,634
Closed -$129K 3767
2026
Q1
$129K Buy
205,634
+1,073
+0.5% +$808 ﹤0.01% 3160
2025
Q4
$180K Hold
204,561
﹤0.01% 3159
2025
Q3
$278K Hold
204,561
﹤0.01% 3077
2025
Q2
$321K Sell
204,561
-41,284
-17% -$76.9K ﹤0.01% 3024
2025
Q1
$649K Hold
245,845
﹤0.01% 2812
2024
Q4
$1.04M Hold
245,845
﹤0.01% 2696
2024
Q3
$816K Hold
245,845
﹤0.01% 2844
2024
Q2
$760K Sell
245,845
-195,044
-44% -$642K ﹤0.01% 2848
2024
Q1
$1.78M Sell
440,889
-64,988
-13% -$245K ﹤0.01% 2453
2023
Q4
$2.83M Buy
505,877
+97,189
+24% +$558K ﹤0.01% 2252
2023
Q3
$2.18M Buy
408,688
+79,822
+24% +$648K ﹤0.01% 2262
2023
Q2
$3.08M Buy
328,866
+3,423
+1% +$30K ﹤0.01% 2147
2023
Q1
$2.81M Sell
325,443
-269,033
-45% -$2.37M ﹤0.01% 2194
2022
Q4
$4.2M Sell
594,476
-249,595
-30% -$2.09M ﹤0.01% 2010
2022
Q3
$8.37M Buy
844,071
+608,096
+258% +$5.49M ﹤0.01% 1593
2022
Q2
$1.68M Buy
+235,975
New +$1.72M ﹤0.01% 2521

Other funds holding DCGO

Nuveen's DCGO Position: Q2 2026 in Review

Nuveen sold out of DocGo (DCGO) in Q2 2026, closing a stake of 205,634 shares — an estimated $129K sold.

Nuveen first reported a position in DCGO in Q2 2022 and held it in 16 quarters. The position peaked at $8.37M in Q3 2022. 119 funds tracked by Wall St. Rank hold DCGO as of Q2 2026.

  • Nuveen reported no remaining DocGo position as of Q2 2026 after selling out during the quarter.
  • Nuveen sold 205,634 DocGo shares in Q2 2026, an estimated $129K.
  • Nuveen first reported a position in DocGo in Q2 2022 and held it in 16 quarters.
  • Nuveen's DocGo position peaked at $8.37M in Q3 2022.
  • 119 funds tracked by Wall St. Rank held DocGo as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.